Alerts
Blog Entries - 'Sesame'
Chunwei, Inc. Recalls Meat and Poultry Products Due to Misbranding and Undeclared Allergens and Monosodium Glutamate
EDITOR’S NOTE: This release was updated on Dec. 22, 2018 to reflect additional poundage. WASHINGTON, Nov. 23, 2018 – Chunwei, Inc., a Huntington Park, Calif. establishment, is recalling
U.S. FDA Approves Kaléo’s AUVI-Q® (Epinephrine Injection, USP) 0.1 mg AutoInjector for Life-Threatening Allergic Reactio
-- First and only epinephrine auto-injector (EAI) approved with a needle length and dose specifically designed for infants and children weighing 16.5 to 33 pounds (7.5 to 15 kilograms) -- Anaphylaxis and food
Kaléo Donates Thousands of AUVI-Q® (epinephrine injection, USP) and EVZIO® (naloxone HCl Injection) Auto-injectors to Hu
-- Direct Relief to distribute 25,000 auto-injectors to partner clinics serving storm-impacted communities -- Richmond, VA (September 1, 2017) Kaléo, a privately-held pharmaceutical company, today announced a
Hurricane Harvey Relief Efforts in Houston, SanAntonio, and More
Texas was hit very hard by Hurricane Harvey and the rain is still coming. San Antonio didn’t get much compared to other locations. Many of the people who have been evacuated from the coast are already here in San
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and S
-- AUVI-Q® (epinephrine injection, USP) 0.1 mg could be the first auto-injector approved with a needle length and dose specifically designed for infants and small children -- -- Emergency room visits due to
KALÉO ANNOUNCES U.S. AVAILABILITY AND PRICING TO PATIENTS OF AUVI-Q® (Epinephrine Injection, USP) AUTO-INJECTOR, FOR LIF
AUVI-Q will be available by prescription nationwide on February 14, 2017. Kaléo launches AUVI-Q AffordAbility, a first-of-its-kind access program and commitment for AUVI-Q: o More than 200 million Americans